Daiichi Sankyo (United States)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
42%
Total
Publications
1.5K
Total Open
Publications
653
Total
Citations
52K
Open Access
Percentage
42%
Total
Publications
1.5K
Total Open
Publications
653
Total
Citations
52K
Breakdown
Publisher Open
19%
Both
19%
Other Platform Open
4%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 34%
197
Hybrid 28%
163
No Guarantees 38%
216
Other Platform Open
Domain 82%
300
Institution 23%
85
Other Internet 12%
42
Public 2%
6
Preprint 1%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 300 |
DOI | Other Internet | 39 |
DANS - Data Archiving and Networked Services | Institution | 37 |
universiteitleiden.nl OAI-PMH Repository | Institution | 10 |
Europe PMC | Domain | 10 |
DASH - Digital Access to Scholarship at Harvard | Institution | 8 |
Yonsei University Medical Library - YUHSpace | Institution | 7 |
Digital Access to Libraries | Institution | 6 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 5 |
Figshare | Public | 5 |